This finding was close to that reported (65%) among American patients with type 1 or type 2 diabetes [15] and much lower than another study (87.5%) focusing on patients with type 1 diabetes users of insulin pump therapy [20]. This evidence concerns the gene INS and type 1 diabetes mellitus.